One of the big sticking points in the TTIP talks has been the EU’s prohibition on imports of beef treated with growth hormones. EU officials continue to insist the issue is off the table, but U.S. officials keep pushing it right back on. Just this week, U.S. Secretary of Agriculture Tom Vilsack told reporters at Politico that EU restrictions on hormone beef (and GMOs) were problem areas in the trade talks. “We should be given an equal opportunity to make the case [for U.S. farm products],” Vilsack said. “It may very well be that European consumers decide not to buy product from the United States, but they ought to be given the choice.”
Well, in fact they are given the choice. According to a new report by Vilsack’s own Department of Agriculture, U.S. sales to Europe of beef raised without hormones have increased substantially over the last few years. It’s an interesting story of a trade dispute spurring new, and apparently profitable, changes in production.
The EU has banned the use of growth-promoting hormones in beef since 1989 over concerns about the safety for human health. The U.S. and Canada won a WTO challenge to that decision at the WTO, winning the right to impose retaliatory tariffs on EU farm goods. In the meantime, USDA’s Agricultural Marketing Service began a Non-Hormone Treated Cattle Program, which certifies U.S. beef for export to the EU.
New research shows that production from organic agriculture shapes up better against input-heavy conventional agriculture than previously thought; meanwhile, evidence for the benefits of agroecology continues to accumulate
A new study was released today examining that evergreen chestnut (to mix metaphors): does “organic agriculture” have lower yields than “conventional agriculture”? Published in the prestigious scientific journal Proceedings of the Royal Society of London by researchers at the University of California, Berkeley, the study found that some previous estimates comparing organic agriculture’s productivity were too low. What’s more, they found that there was a bias in the data in favor of conventional agriculture, which means even their updated estimate may still overestimate in favor of the current resource-intensive, high-input systems that dominate much of agriculture today.
How much would you pay for a pork chop that was two percent leaner? Would you eat such a pork chop if nanoscale minerals were mixed into the hog feed to achieve that two percent reduction? Such questions are before the Food and Drug Administration (FDA) as it considers what to advise the animal feed and mineral supplement industry about their efforts to incorporate atomic- to molecular-sized materials into feed.
This summer, the FDA requested comment on what to advise the animal feed industry about nanomaterials. IATP and others have repeatedly called for the FDA to require pre-market and post-market safety assessment of nanomaterials prior to their commercialization. To the latest FDA request, IATP responded that if FDA continues to not require adequate pre- and post-market safety assessments, it should at least strongly urge the industry to report to FDA in great detail about its nano-feed products. We also said that industry reported data affecting public health, the environment and worker safety should be not classified as Confidential Business Information (CBI) not available to the public.
Earlier this summer, the U.S. Food and Drug Administration (FDA) advised the food industry what a manufacturer should do if it puts nanomaterials in food: Please call us. The human health effects of ingesting nanomaterials are not well understood, but a few food manufacturers claim to include nanomaterials in their products. The FDA’s advice could have been worse: Don’t call us. But it could have been a lot better by requiring pre-market and post-market safety assessments and testing of any “food substance” containing nanomaterials.
Nanotechnology, the synthesis, visualization, configuration and manipulation of atomic to molecular size particles, has been practicable since the Nobel-prize winning invention in 1981 of a kind of microscope that made nano-visualization and manipulation possible. (See the superb “Timeline: Nanotechnology” published in April by the University of Ottawa.) The application of nanotechnology to industrial processes, such as coating semi-conductors and other electronic parts with infinitesimally thin layers of metal oxides, has enabled the production of computer server farms and cell-phones, to name just two of the most famous applications.
Synthetic biology is “Still in [the] Uncharted Waters of Public Opinion,” according to a recent focus group study by the Woodrow Wilson Center for International Scholars. That’s not surprising since the technology involved sounds like something out of science fiction. It includes a range of techniques to modify organisms using artificially constructed sequences of genetic information (DNA) not found in nature. The Center’s Synthetic Biology Project gives an introduction to this discipline, sometimes referred to as “synbio.”
The advancement of synbio has taken place largely under the radar, with little public debate, but that’s changing. A June 17 criticism of an NGO synbio letter by an industry lobbyist, published on the investor website The Motley Fool, served to put more of a spotlight on the issue. The Motley Fool blog was almost immediately rebutted by Synbio Watch.
The Antibiotic Resistance Coalition, comprising civil society organizations including IATP and stakeholders from multiple sectors on six continents, has called on World Health Organization (WHO) Member States to pass a critical resolution (Combating antimicrobial resistance, including antibiotic resistance) at the 67th World Health Assembly (WHA). That resolution would spark concerted global action to control the escalating antimicrobial resistance crisis.
Governments meet at the WHA annually to decide on a host of critical global health issues. Meeting from May 19–24, one of the most urgent actions this year must be a strong resolution against the spread of antimicrobial resistance (which includes the increasing resistance of antibiotics to simple infections) and to launch a global strategy that coordinates action against its spread, which has reached crisis levels across national boundaries.
The Obama Administration’s feverish cheerleading for genetically modified crops is being put to the test with growing evidence that the technology is unpopular with consumers, causing problems in the field and facing increasing rejection in the marketplace.
The state of Vermont is set to become the first in the country to require mandatory labeling of genetically modified foods. Maine and Connecticut have also passed mandatory labeling bills, but they require neighboring states to also pass such bills before they come into law. More than 25 states have GMO labeling laws working their way through state legislatures and ballot initiatives. Hawaii, a major testing ground for new GMO crops, has become another battleground as several counties now require greater disclosure and tougher regulations for GMO plantings.
This is a big deal and the biotech seed industry knows it. The industry has already spent millions to defeat ballot initiatives and state-based bills. Its next line of defense against the states is litigation, where it will likely sue states’ requiring labeling for violating the interstate commerce clause (restricting trade between states).
We’ve all made recipes and forgot that one key ingredient, only to forgive ourselves because, after all, food is more than just its physical ingredients: Too salty or not, we made that soup and we’ll be damned if we’re not proud of ourselves.
So what about the food we buy? Other than the items listed on the nutrition facts, food companies know we want to feel good: “The Breakfast of Champions” or something that’s “Mmm Mmm Good.” These famous slogans say nothing of ingredients, and everything about emotional appeal. Of course, advertising doesn’t include the whole story: The U.S. food system, controlled by a handful of corporations, is missing some key ingredients. We know there’s plenty of salt, sugar and fat, replacing the ingredients we might use at home, the freshness or family recipes we might cherish, and greater nutrition and variety provided by whole and home-cooked foods. In the same way, fair wages and prices for workers and farmers in the food system have been replaced with huge volumes of cheap food (and accompanying waste), low prices and inadequate wages.
From the soil and water that feeds our crops, to the waiters and waitresses that serve us our lunch, to the seeming myriad choices we have at the grocery store about what we eat, justice and health for ourselves, our farmers, workers and the environment is in drastically short supply.
A minimum of 23,000 people die in the United States due to antibiotic resistance, according to the Center for Disease Control. Yet, antibiotic resistance—the rise of so-called “super bugs”—is on the rise because of overuse and abuse of antibiotics in our food system. Eighty percent of antibiotics sold in the U.S. go toward food animal production—mostly for the corporate meat industry that uses it for growth promotion and to keep a large number of animals alive in confined spaces. While doctors, nurse practitioners and pharmacists are required to write prescriptions for antibiotics to treat sick people, anyone can buy them over the counter in animal feed stores. This lack of regulation is creating a public health crisis that is entirely possible to avert.
After years of delay, FDA is finally attempting to address this major gap by requiring animal drug makers to have veterinary supervision of antibiotics in feed. Veterinary supervision is critical to slow the overuse of these drugs and the related spread of antibiotic resistance. However, the FDA (in order avoid resistance from drug companies) is watering down what “veterinary supervison” means, and therefore, undermining the ability of government agencies to effectively track how drugs in animal feed are used.
The existing rule (called the Veterinary Feed Directive, or VFD), which is stronger, only applies to two drugs. But the FDA is weakening this rule in order to apply it to many more antibiotic drugs. While regulating a broad range of antibiotics under the VFD is absolutely critical for public health, the FDA should create a strong and comprehensive rule that requires the drug industry to change its practices.
To read the proposed FDA rule, click here.
Busy hands make for busy minds—that’s the theory behind experiential, or hands-on learning. IATP’s new high school–level Farm to School Youth Leadership Curriculum, released today, is designed with this in mind: Beyond learning about sourcing local food and the research that goes into localizing their school lunch, students actually participate in creating or expanding a Farm to School program, assisting their school lunchroom staff and administration with the nitty gritty of sourcing local foods for lunch.
From the press release:
The Farm to School Youth Leadership Curriculum is comprised of six lessons that can be taught consecutively over a semester or as single lessons or activities to complement other classes. Each lesson contains a lesson summary, facilitator preparation notes, activities, worksheets, recommended optional work and further resources for students and teachers. Lessons include themes such as “School Lunch: How Does it Really Work?” and “Communicating with Producers of Local Foods.”
Development of the Farm to School Youth Leadership Curriculum was a collaborative process, including consultation with educators, food service professionals and Farm to School experts, supported by the Center for Prevention at Blue Cross and Blue Shield of Minnesota, the John P. and Eleanor R. Yackel Foundation, the Minnesota Agricultural Education Leadership Council and the Minnesota Department of Agriculture.